17th Conference on Retroviruses and Opportunistic Infections (CROI) 16-19 February 2010, San Francisco
1 June 2010. Related: Conference reports.
CROI 17 (Retrovirus) 2010
HIV reinfection cases reported at CROI
1 June 2010. Related: Conference reports, HIV prevention and transmission, Virology.
Hepatitis studies: IL28B genetics, HCV survival, FibroScan in acute HCV, MSM reinfection and responses to transplantation
1 June 2010. Related: Conference reports, Hepatitis coinfection.
Poor bioequivalence with crushed and dissolved tablets
1 June 2010. Related: Conference reports, Paediatric care, PK and drug interactions.
Initial PK, safety and 12 week efficacy of raltegravir chewable tablets in children 6-11 years
1 June 2010. Related: Conference reports, Paediatric care.
PK of efavirenz in children dosed according to WHO weight bands
1 June 2010. Related: Conference reports, Paediatric care.
Virological and immunological responses in infants enrolled in the CHER trial
1 June 2010. Related: Conference reports, Paediatric care.
Darunavir-associated mutations in PI-naive and PI-experienced children in the UK
1 June 2010. Related: Conference reports, Paediatric care, Drug resistance.
HIV persistence, raltegravir/maraviroc intensification and immunology
1 June 2010. Related: Conference reports, Basic science and immunology.
Volume 11 Number 3/4 March/April 2010
2 April 2010. Related: Editorial.
17th Conference on Retroviruses and Opportunistic Infections (CROI), 16-19 February 2010, San Francisco
2 April 2010. Related: Conference reports.
Treatment reduces infections by over 90%: a theme that is here to stay
2 April 2010. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
ACTG 5205: atazanavir/ritonavir vs efavirenz in treatment naive patients
2 April 2010. Related: Conference reports, Antiretrovirals, Side effects, Lipodystrophy and metabolic complications.
Pipeline compounds and new approaches to treatment
2 April 2010. Related: Conference reports, Antiretrovirals.
Clinical benefits of stopping smoking: CVD and CHD risk returns to that of ‘previous smoker’ in HIV-positive people within three years
2 April 2010. Related: Conference reports, Lipodystrophy and metabolic complications, Cancer and HIV.
HIV increases the risk of lung cancer, independent of smoking status
2 April 2010. Related: Conference reports, Cancer and HIV.
HIV positive people in the HOPS cohort have 4-fold risk of fracture compared to general population in the US
2 April 2010. Related: Conference reports, Side effects.
Vitamin D deficiencies in HIV management
2 April 2010. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
OCTANE 2: nevirapine and lopinavir/r are similar when used with tenofovir and FTC in treatment-naive women
2 April 2010. Related: Conference reports, Pregnancy.
HIV incidence and retesting in pregnancy
2 April 2010. Related: Conference reports, Pregnancy.
Efavirenz use in pregnancy and birth outcomes
2 April 2010. Related: Conference reports, Pregnancy.
Pregnancy outcomes in women using non-AZT HAART in Europe
2 April 2010. Related: Conference reports, Pregnancy.
When should HAART be initiated in pregnancy to achieve an undetectable viral load?
2 April 2010. Related: Conference reports, Pregnancy.
Pregnancy outcomes in infants exposed to maternal antiretrovirals in utero
2 April 2010. Related: Conference reports, Pregnancy, Paediatric care.
Maternal TB, HIV and pregnancy
2 April 2010. Related: Conference reports, Women's health, Pregnancy, TB coinfection.